Search research articles
Contact Us
Filters
Showing results (31-40 of 231) with videos related to
Page
of 24
Sort By:
Current Opinion in Urology
|
June 7, 2024
Footprints in the scan: reducing the carbon footprint of diagnostic tools in urology
Alexandre Woernle, Caroline M Moore, Clare Allen, et al.
European Urology
|
August 12, 2019
Reply to Francesco Montorsi, Giorgio Gandaglia, Alberto Briganti's Letter to the Editor, re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review, Meta-analysis. Eur Urol 2019;76:284-303: The choice of diagnostic test in prostate cancer is a balance of the risks and benefits: One size may not fit all
Veeru Kasivisvanathan, Yemisi Takwoingi, Mark Emberton, et al.
European Urology
|
February 6, 2021
The Importance of Being PRECISE in Prostate Magnetic Resonance Imaging and Active Surveillance
Francesco Giganti, Veeru Kasivisvanathan, Clare Allen, et al.
European Urology
|
July 27, 2020
Reply to Francesco Montorsi, Giorgio Gandaglia, Nicola Fossati, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51
Vasilis Stavrinides, Francesco Giganti, Mark Emberton, et al.
European Urology Oncology
|
September 18, 2023
Reply to Jorge Abreu-Gomez, Masoom Haider, and Sangeet Ghai's Letter to the Editor re: Francesco Giganti, Louise Dickinson, Clement Orczyk, et al. Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. Eur Urol Oncol. 2023;6:629-634
Francesco Giganti, Louise Dickinson, Clare Allen, et al.
Radiologic Clinics of North America
|
November 16, 2023
Active Surveillance for Prostate Cancer: Expanding the Role of MR Imaging and the Use of PRECISE Criteria
Cameron Englman, Tristan Barrett, Caroline M Moore, et al.
Prostate Cancer and Prostatic Diseases
|
August 18, 2018
MRI in active surveillance: a critical review
Vasilis Stavrinides, Francesco Giganti, Mark Emberton, et al.
European Urology
|
November 30, 2019
Magnetic Resonance Imaging Should Be Used in the Active Surveillance of Patients with Localised Prostate Cancer
Veeru Kasivisvanathan, Francesco Giganti, Mark Emberton, et al.
European Urology
|
July 13, 2020
Reply to Carissa E. Chu, Peter E. Lonergan, and Peter R. Carroll's Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51
Vasilis Stavrinides, Francesco Giganti, Mark Emberton, et al.
Nature Reviews. Urology
|
January 31, 2020
Mycobacterial immunotherapy for prostate cancer: where can we go from here?
Vasilis Stavrinides, Angus Dalgleish, John P Copier, et al.
Page
of 24
Search research articles
Search
Showing results (31-40 of 231) with videos related to
Sort By:
Page
of 24
Current Opinion in Urology
|
June 7, 2024
Footprints in the scan: reducing the carbon footprint of diagnostic tools in urology
Alexandre Woernle, Caroline M Moore, Clare Allen, et al.
European Urology
|
August 12, 2019
Reply to Francesco Montorsi, Giorgio Gandaglia, Alberto Briganti's Letter to the Editor, re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review, Meta-analysis. Eur Urol 2019;76:284-303: The choice of diagnostic test in prostate cancer is a balance of the risks and benefits: One size may not fit all
Veeru Kasivisvanathan, Yemisi Takwoingi, Mark Emberton, et al.
European Urology
|
February 6, 2021
The Importance of Being PRECISE in Prostate Magnetic Resonance Imaging and Active Surveillance
Francesco Giganti, Veeru Kasivisvanathan, Clare Allen, et al.
European Urology
|
July 27, 2020
Reply to Francesco Montorsi, Giorgio Gandaglia, Nicola Fossati, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51
Vasilis Stavrinides, Francesco Giganti, Mark Emberton, et al.
European Urology Oncology
|
September 18, 2023
Reply to Jorge Abreu-Gomez, Masoom Haider, and Sangeet Ghai's Letter to the Editor re: Francesco Giganti, Louise Dickinson, Clement Orczyk, et al. Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. Eur Urol Oncol. 2023;6:629-634
Francesco Giganti, Louise Dickinson, Clare Allen, et al.
Radiologic Clinics of North America
|
November 16, 2023
Active Surveillance for Prostate Cancer: Expanding the Role of MR Imaging and the Use of PRECISE Criteria
Cameron Englman, Tristan Barrett, Caroline M Moore, et al.
Prostate Cancer and Prostatic Diseases
|
August 18, 2018
MRI in active surveillance: a critical review
Vasilis Stavrinides, Francesco Giganti, Mark Emberton, et al.
European Urology
|
November 30, 2019
Magnetic Resonance Imaging Should Be Used in the Active Surveillance of Patients with Localised Prostate Cancer
Veeru Kasivisvanathan, Francesco Giganti, Mark Emberton, et al.
European Urology
|
July 13, 2020
Reply to Carissa E. Chu, Peter E. Lonergan, and Peter R. Carroll's Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51
Vasilis Stavrinides, Francesco Giganti, Mark Emberton, et al.
Nature Reviews. Urology
|
January 31, 2020
Mycobacterial immunotherapy for prostate cancer: where can we go from here?
Vasilis Stavrinides, Angus Dalgleish, John P Copier, et al.
Page
of 24